IDIBELL researchers discover a substance against the 'dark genome' of cancer
2011-03-01
(Press-News.org) A research study coordinated by Manel Esteller, researcher at Bellvitge Biomedical Research Institute (IDIBELL) has identified a substance that inhibits cancer growth by activating the so‑called "dark genome" (or non‑coding DNA) and micro‑RNA molecules. The study appears this week in the journal Proceedings of the National Academy of Sciences (PNAS).
Human body cells have a genome (the set of our DNA) encoding our proteins such as keratin in the skin or haemoglobin in blood. This genome with encoding DNA represents only the 5% of our genetic material. The remaining 95% is called the 'dark genome' or non-coding DNA and its role is largely unknown. Part of this DNA produces small charged molecules called micro-RNAs that activate or deactivate genes. In recent years it has been shown that alterations in these molecules are related to tumour onset.
Enoxacine
Researchers have shown that a small-molecule called enoxacin, used in antibacterial compounds, binds to the protein that builds micro-RNA and stimulates their inhibitory activity of the tumour growth. According to researcher Manel Esteller, that "is like if we have a second hand car and we put on a new engine".
The molecule has been tested both in laboratory cells and in animal models and now its behaviour should be studied in humans. Esteller stresses that the advantage of this compound is that we know its metabolism and its human security. Esteller adds that "although the use of this molecule may not be approved in cancer treatment, this finding opens the door to design new drugs that use microRNA as a therapeutic target. We show the pharmaceutical industry a new direction where to direct their efforts in anti-tumour therapy."
INFORMATION:
Article reference
Sonia Melo, Alberto Villanueva, Catia Moutinho, Verónica Davalos, Ricardo Spizzo, Cristina Ivan , Simona Rossi, Fernando Setien, Oriol Casanovas, Laia Sio-Riudalbas, Javier Carmona, Jordi Carrere, August Vidal, Álvaro Aytes, Sara Puertas, Santiagio Ropero, Raghu Kalluri, Carlo M. Croce, George A. Calin, Manel Esteller. The small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TRBP-mediated microRNA processing. Proceedings of the National Academy of Science USA (PNAS), Early Edition, February 28th 2011.
Who we are
Bellvitge Institute for Biomedical Research (IDIBELL) is a research center created in 2004 with the participation of the Bellvitge University Hospital, the Catalan Institute of Oncology, the University of Barcelona, and the Institute of Image Diagnosis. IDIBELL is integrated in Biopol'H, the health and scientific park of l'Hospitalet de Llobregat-Barcelona-Spain.
END
ELSE PRESS RELEASES FROM THIS DATE:
2011-03-01
About 1,200 criminal justice researchers as well as active and retired law-enforcement professionals from around the world are expected to attend the annual meeting of the international Academy of Criminal Justice Sciences, to be held March 1-5 in Toronto. Presentations of the latest research in the field will be made, including research presented by the University of Cincinnati faculty and students.
Recognized at the conference will be UC researchers Bonnie Fisher, professor, and Francis Cullen, distinguished professor. Fisher and Cullen will receive the 2010 Outstanding ...
2011-03-01
Researchers from Boston University School of Medicine (BUSM) have found that patients with node negative T3 and T4 non-small lung cancer who underwent chemotherapy before surgery had more than three times the survival rate than patients who only underwent surgery. These findings currently appear on-line in the Journal of Thoracic and Cardiovascular Surgery.
The study looked at a total of 110 patients who underwent surgical resection for invasive T3 and T4 non-small lung cancer between 1979 and 2008. Forty-seven patients received neoadjuvant chemotherapy and concurrent ...
2011-03-01
AMES, Iowa - A protein pathway that may hold the secret to understanding Parkinson's disease has been discovered and explained by Iowa State University researchers.
Anumantha Kanthasamy, a distinguished professor of biomedical sciences and the W. Eugene and Linda R. Lloyd Endowed Chair in Neurotoxicology at the ISU College of Veterinary Medicine, has been working to understand the complex mechanisms of the disease for more than a decade. He believes this recent discovery offers hope for the cure.
The research was funded by the National Institutes of Health and is published ...
2011-03-01
WASHINGTON, February 28, 2011) – Results from a study published in Blood, the Journal of the American Society of Hematology reveal a close relationship between pulmonary arterial hypertension (PAH)—exceedingly high blood pressure in the arteries carrying blood from the heart to the lungs—and abnormalities of the blood-forming cells in the bone marrow (known as myeloid abnormalities).
The study, which was conducted by a team of researchers at the Cleveland Clinic, showed that blood progenitor cells (cells that are capable of forming white blood cells, red blood cells, ...
2011-03-01
A new University of Colorado Boulder study indicates an ancient form of complementary medicine may be effective in helping to treat people with mild traumatic brain injury, a finding that may have implications for some U.S. war veterans returning home.
The study involved a treatment known as acupressure in which one's fingertips are used to stimulate particular points on a person's body -- points similar to those stimulated with needles in standard acupuncture treatments, said CU-Boulder Professor Theresa Hernandez, lead study author. The results indicate a link between ...
2011-03-01
ATLANTA –February 28, 2011– A sharp decline in breast cancer incidence rates among non-Hispanic white women in the U.S. after a dramatic drop in the use of postmenopausal hormone therapy did not continue through 2007, according to a new study from the American Cancer Society and the National Cancer Institute. While there are several possible explanations for the recent stabilization, it may indicate that the decrease in breast cancers thought to be related to postmenopausal hormone use has bottomed out. The study appears online in Cancer Epidemiology Biomarkers and Prevention ...
2011-03-01
Troy, N.Y. – Benjamin Clough has developed a novel method for eavesdropping on terahertz information hidden in invisible plasma acoustic bursts. The doctoral student at Rensselaer Polytechnic Institute has demonstrated a promising technique that employs sound waves to boost the distance from which researchers can use powerful terahertz technology to remotely detect hidden explosives, chemicals, and other dangerous materials.
Clough, a student in the Department of Electrical, Computer, and Systems Engineering at Rensselaer, is one of three finalists for the 2011 $30,000 ...
2011-03-01
New York University physicists have developed a method for packing microscopic spheres that could lead to improvements in commercial products ranging from pharmaceutical lotions to ice cream. Their work, which relies on an innovative application of statistical mechanics, appears in the Proceedings of the National Academy of Sciences.
The study aimed to manipulate the properties of emulsions, which are a mixture of two or more immiscible liquids. The NYU researchers examined droplets of oil in water, which form the basis of a range of consumer products, including butter, ...
2011-03-01
New York University researchers have isolated neural activity that reflects basic mechanisms used by the brain to combine elementary pieces of language in order to construct complex ideas.
The study, which appears in the Journal of Neuroscience, was conducted by Douglas Bemis, a graduate student in NYU's Department of Psychology, and Liina Pylkkänen, an associate professor in NYU's Department of Psychology and Department of Linguistics.
Researchers have long studied the neural regions that underlie the processing of complete sentences and other complex linguistic ...
2011-03-01
More than 45 years after the Civil Rights Act of 1964, National Science Foundation (NSF) statistics show minority academic institutions still enroll a substantial number of minority students, but the percentage of minorities earning bachelor's degrees in science and engineering (S&E) from minority-serving institutions has declined over time.
Statistics published today in a report titled "Women, Minorities, and Persons with Disabilities in Science and Engineering: 2011" show that 26 percent of blacks earned S&E bachelor's degrees from historically black colleges and universities ...
LAST 30 PRESS RELEASES:
[Press-News.org] IDIBELL researchers discover a substance against the 'dark genome' of cancer
